Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 23;13(9):1520.
doi: 10.3390/diagnostics13091520.

Use of the Dialkylcarbamoylchloride Dressing in the Care of Central Venous Access Exit Site in a Pediatric and Neonatal Population

Affiliations

Use of the Dialkylcarbamoylchloride Dressing in the Care of Central Venous Access Exit Site in a Pediatric and Neonatal Population

Giorgio Lamberti et al. Diagnostics (Basel). .

Abstract

Dialkylcarbamoylchloride dressing is a fatty acid derivative that has been shown in vitro to bind a number of pathogenic microorganisms. The purpose of this prospective study was to evaluate the safety and the efficacy of this technology in the care of the exit site of central venous catheter in a paediatric and neonatal population.

Methods: The study was conducted from September 2020 to December 2022 at the Infermi Hospital in Rimini. Central venous catheters were placed using the SIC bundle for insertion. Dialkylcarbamoylchloride dressing was placed below the subcutaneous anchoring at the time of CVC placement and at each dressing change. Data about the catheters and the exit site were recorded and then compared with an historical cohort.

Results: 118 catheters were placed during the studied period. The dialkylcarbamoylchloride dressing was well-tolerated. No case of systemic or local infection was recorded. The comparison with the historical cohort showed a reduction in the rate of exit site infection (p value 0.03).

Conclusion: Dialkylcarbamoylchloride dressing is well-tolerated in paediatric and neonatal population. It represents a promising tool as a strategy for infection prevention.

Keywords: central venous catheter; dialkylcarbamoylchloride; dressing; exit site; exit site infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
DACC dressing.
Figure 2
Figure 2
Centrally inserted central catheter in a paediatric patient stabilized with Securacath. DACC dressing is placed below the Securacath.

References

    1. Lamperti M., Bodenham A.R., Pittiruti M., Blaivas M., Augoustides J.G., Elbarbary M., Pirotte T., Karakitsos D., LeDonne J., Doniger S., et al. International evidence-based recommendations on ultrasound-guided vascular access. Intensiv. Care Med. 2012;38:1105–1117. doi: 10.1007/s00134-012-2597-x. - DOI - PubMed
    1. Cellini M., Bergadano A., Crocoli A., Badino C., Carraro F., Sidro L., Botta D., Pancaldi A., Rossetti F., Pitta F., et al. Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease. J. Vasc. Access. 2022;23:3–17. doi: 10.1177/1129729820969309. - DOI - PubMed
    1. Gorski L.A.M., Hadaway L.M., Hagle M.E.P., Broadhurst D.M., Clare S.M., Kleidon T.M.P., Meyer B.M.P., Nickel B.A.-C., Rowley S.M., Sharpe E.D., et al. Infusion Therapy Standards of Practice, 8th Edition. J. Infus. Nurs. 2021;44:S1–S224. doi: 10.1097/NAN.0000000000000396. - DOI - PubMed
    1. Acosta C., Tusman G. Ultrasound-guided brachiocephalic vein access in neonates and pediatric patients. Rev. Esp. Anestesiol. Reanim. 2021;68:584–591. doi: 10.1016/j.redar.2020.10.016. - DOI - PubMed
    1. Feller-Kopman D. Ultrasound-guided internal jugular access: A proposed standardized approach and implications for training and practice. Chest. 2007;132:302–309. doi: 10.1378/chest.06-2711. - DOI - PubMed

LinkOut - more resources